June 13, 2024 | Press Release
MINNEAPOLIS — Today the U.S. Supreme Court ruled that the plaintiffs in FDA v. Alliance for Hippocratic Medicine do not have legal standing. The case was brought by health care professionals arguing that the FDA illegally approved and then expanded access to the abortion drug mifepristone at the expense of women’s safety. The Court did not rule on the merits of the challenge.
The following statement may be attributed to MCCL Co-Executive Director Cathy Blaeser:
"Chemical abortions pose serious risks to pregnant women. And the Biden administration's rollback of longstanding safety protocols—even allowing these drugs to be sent through the mail, with no in-person medical evaluation first—only increases the danger. We urge policymakers to restore commonsense protections and safeguards for women and their babies."
For additional information about the risks of chemical abortions, see Dr. Randall O’Bannon's recent article on the complication rates of mifepristone. See also National Right to Life's white paper What the Media Missed in Its Coverage of the U.S. Fifth Circuit Court of Appeals Decision Regarding Mifepristone.